BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 30925311)

  • 21. Prognostic value of
    Lu RQ; Wu LX; Zhang J; Qin YZ; Liu YR; Lai YY; Jiang H; Chang YJ; Ruan GR; Huang XJ
    Hematology; 2021 Dec; 26(1):9-15. PubMed ID: 33357137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cysteine and glycine-rich protein 2 (CSRP2) transcript levels correlate with leukemia relapse and leukemia-free survival in adults with B-cell acute lymphoblastic leukemia and normal cytogenetics.
    Wang SJ; Wang PZ; Gale RP; Qin YZ; Liu YR; Lai YY; Jiang H; Jiang Q; Zhang XH; Jiang B; Xu LP; Huang XJ; Liu KY; Ruan GR
    Oncotarget; 2017 May; 8(22):35984-36000. PubMed ID: 28415593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential expression pattern of protein markers for predicting chemosensitivity of dexamethasone-based chemotherapy of B cell acute lymphoblastic leukemia.
    Dehghan-Nayeri N; Eshghi P; Pour KG; Rezaei-Tavirani M; Omrani MD; Gharehbaghian A
    Cancer Chemother Pharmacol; 2017 Jul; 80(1):177-185. PubMed ID: 28585036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pediatric-Like Acute Lymphoblastic Leukemia Therapy in Adults With Lymphoblastic Lymphoma: The GRAALL-LYSA LL03 Study.
    Lepretre S; Touzart A; Vermeulin T; Picquenot JM; Tanguy-Schmidt A; Salles G; Lamy T; Béné MC; Raffoux E; Huguet F; Chevallier P; Bologna S; Bouabdallah R; Benichou J; Brière J; Moreau A; Tallon-Simon V; Seris S; Graux C; Asnafi V; Ifrah N; Macintyre E; Dombret H
    J Clin Oncol; 2016 Feb; 34(6):572-80. PubMed ID: 26644537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic and therapeutic role of targetable lesions in B-lineage acute lymphoblastic leukemia without recurrent fusion genes.
    Messina M; Chiaretti S; Wang J; Fedullo AL; Peragine N; Gianfelici V; Piciocchi A; Brugnoletti F; Di Giacomo F; Pauselli S; Holmes AB; Puzzolo MC; Ceglie G; Apicella V; Mancini M; Te Kronnie G; Testi AM; Vitale A; Vignetti M; Guarini A; Rabadan R; Foà R
    Oncotarget; 2016 Mar; 7(12):13886-901. PubMed ID: 26883104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inotuzumab ozogamicin in relapsed B-cell acute lymphoblastic leukemia.
    Thota S; Advani A
    Eur J Haematol; 2017 May; 98(5):425-434. PubMed ID: 28152223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IKAROS Gene Deleted B-Cell Acute Lymphoblastic Leukemia in Mexican Mestizos: Observations in Seven Patients and a Short Review of the Literature.
    Ruiz-Delgado GJ; Cantero-Fortiz Y; León-Peña AA; León-González M; Nuñez-Cortés AK; Ruiz-Argüelles GJ
    Rev Invest Clin; 2016; 68(4):210-4. PubMed ID: 27623040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High RASD1 transcript levels at diagnosis predicted poor survival in adult B-cell acute lymphoblastic leukemia patients.
    Wang S; Wang C; Wang W; Hao Q; Liu Y
    Leuk Res; 2019 May; 80():26-32. PubMed ID: 30925311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.
    Tzortzatou-Stathopoulou F; Papadopoulou AL; Moschovi M; Botsonis A; Tsangaris GT
    J Pediatr Hematol Oncol; 2001 Dec; 23(9):591-7. PubMed ID: 11902303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myeloproliferative neoplasms with t(8;22)(p11.2;q11.2)/BCR-FGFR1: a meta-analysis of 20 cases shows cytogenetic progression with B-lymphoid blast phase.
    Montenegro-Garreaud X; Miranda RN; Reynolds A; Tang G; Wang SA; Yabe M; Wang W; Fang L; Bueso-Ramos CE; Lin P; Medeiros LJ; Lu X
    Hum Pathol; 2017 Jul; 65():147-156. PubMed ID: 28551329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapeutic strategies for childhood high-risk acute lymphoblastic leukemia].
    Lu XT
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):327-32. PubMed ID: 23591360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of residual disease in pediatric B-cell precursor acute lymphoblastic leukemia by comparative phenotype mapping: method and significance.
    Dworzak MN; Fritsch G; Panzer-Grümayer ER; Mann G; Gadner H
    Leuk Lymphoma; 2000 Jul; 38(3-4):295-308. PubMed ID: 10830736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute myelofibrosis terminating in acute lymphoblastic leukemia: case report and review of the literature.
    Dunphy CH; Kitchen S; Saravia O; Velasquez WS
    Am J Hematol; 1996 Jan; 51(1):85-9. PubMed ID: 8571944
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.